Citation: | PENG Shiyan, CHEN Hua, YIN Jie. Determination of azide genotoxic impurity in linezolid API and glucose injection by UPLC-MS/MS[J]. Journal of China Pharmaceutical University, 2022, 53(6): 705-709. DOI: 10.11665/j.issn.1000-5048.20220609 |
[1] |
. Med Mal Infect,2005,35(9):427-434.
|
[2] |
Brickner SJ,Hutchinson DK,Barbachyn MR,et al. Synthesis and antibacterial activity of U-100592 and U-100766,two oxazolidinone antibacterial agents for the potential treatment of multidrug-resistant gram-positive bacterial infections[J]. J Med Chem,1996,39(3):673-679.
|
[3] |
European Medicines Agency. ICH guideline M7(R1) on assessment and control of DNA reactive (mutagenic) impurities in pharmaceuticals to limit potential carcinogenic risk-step 5[EB/OL].(
|
[4] |
Tuberculosis branch of Chinese Medical Association,Expert consensus writing group on linezolid anti-tuberculosis treatment. Expert consensus on anti-tuberculosis treatment with linezolid[J]. Chin J Tuberc Respir Dis(中华结核和呼吸杂志),2018,41(1):14-19.
|